Presenter Speech
Luca Issi (Analysts)
And today, they're a great privilege to have Moderna as part of our 2026 Global Healthcare Conference. Representing the company, we have Lavina Talukdar as Head of
|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 61,56 USD | -0,40 % |
|
+23,66 % | +108,16 % |
| 12:01 | Modernas mRNA-Grippeimpfstoff steht vor kritischer Prüfung durch FDA-Beratergremium | RE |
| 06:51 | PRESSESPIEGEL/Unternehmen | DJ |
Veröffentlicht am 19.05.2026 um 17:35 - Geändert am 19.05.2026 um 18:20
Presenter Speech
Luca Issi (Analysts)
And today, they're a great privilege to have Moderna as part of our 2026 Global Healthcare Conference. Representing the company, we have Lavina Talukdar as Head of
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen